NCT03340025

Brief Summary

Various management options for free flap donor sites that require split thickness skin grafting exist. None has proven superior from both a patient care and a cost standpoint. Major complications occurring at these surgical sites include wound breakdown, tendon exposure, and loss of function. We seek to investigate the use of the PICO single-use negative pressure wound therapy device in these surgical sites and determine if it can yield superior results to simpler methods.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2017

Completed
7 months until next milestone

Study Start

First participant enrolled

June 15, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2020

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2021

Completed
2 months until next milestone

Results Posted

Study results publicly available

July 30, 2021

Completed
Last Updated

July 30, 2021

Status Verified

July 1, 2021

Enrollment Period

1.8 years

First QC Date

November 8, 2017

Results QC Date

June 17, 2021

Last Update Submit

July 12, 2021

Conditions

Keywords

negative pressure wound therapysplit thickness skin graft

Outcome Measures

Primary Outcomes (1)

  • Progression of Wound Healing

    Comparison of photographs of all participants' wounds taken at post-operative Day 5, post-operative Day 14-21, and post-operative Day 30. Percentage skin graft take will be evaluated on Day 30 by blinded, independent raters. A 10x10 grid was digitally overlain on each image. The de-identified images were randomized and given to two independent raters. The raters used three criteria to assess each graft. Overall graft appearance was graded on a 1-5 scale, percent of graft take was estimated, and the presence of exposed tendon was noted for each timepoint.

    Baseline through 30 days

Study Arms (2)

negative pressure wound therapy

EXPERIMENTAL

PICO Single Use Negative Pressure Wound Therapy System

Device: PICO Single Use Negative Pressure Wound Therapy System

conventional dressing

PLACEBO COMPARATOR

traditional surgical wound dressing of xeroform gauze and padding

Device: xeroform gauze

Interventions

Class II negative pressure wound therapy powered suction pump

negative pressure wound therapy

traditional surgical dressing of xeroform gauze and padding

conventional dressing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18 years of age
  • participants are able to consent for themselves
  • undergoing reconstructive surgery requiring split-thickness skin graft coverage of a free flap donor site (i.e., radial forearm free flap or fibula free flap)

You may not qualify if:

  • \< 18 years of age
  • participants are unable to consent for themselves
  • undergoing reconstructive surgery that does not require split-thickness skin graft coverage of a free flap donor site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

Surgical Wound

Condition Hierarchy (Ancestors)

Wounds and Injuries

Limitations and Caveats

The patient population is small. Our statistics indicate that assuming an 80% graft take, the number of patients needed for an appropriately powered study (80%) would be 44 patients in each group, while our study recruited only 9 and 11 patients to each group. This study is limited by missing data. Our study also takes place at a single center and, therefore, surgeon technique must be taken into account as this may have affected the outcomes of our data.

Results Point of Contact

Title
Benjamin Greene, MD
Organization
University of Alabama at Birmingham

Study Officials

  • Benjamin Greene, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 8, 2017

First Posted

November 13, 2017

Study Start

June 15, 2018

Primary Completion

April 13, 2020

Study Completion

June 15, 2021

Last Updated

July 30, 2021

Results First Posted

July 30, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations